BCWORLD PHARM (Korea) Performance

200780 Stock  KRW 4,720  35.00  0.74%   
BCWORLD PHARM has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.26, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BCWORLD PHARM are expected to decrease at a much lower rate. During the bear market, BCWORLD PHARM is likely to outperform the market. BCWORLD PHARM now shows a risk of 2.38%. Please confirm BCWORLD PHARM jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to decide if BCWORLD PHARM will be following its price patterns.

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BCWORLD PHARM Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BCWORLD PHARM may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
Total Cashflows From Investing Activities-18.8 B
  

BCWORLD PHARM Relative Risk vs. Return Landscape

If you would invest  443,070  in BCWORLD PHARM Co on October 13, 2024 and sell it today you would earn a total of  28,930  from holding BCWORLD PHARM Co or generate 6.53% return on investment over 90 days. BCWORLD PHARM Co is generating 0.1296% of daily returns and assumes 2.3757% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than BCWORLD, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon BCWORLD PHARM is expected to generate 2.88 times more return on investment than the market. However, the company is 2.88 times more volatile than its market benchmark. It trades about 0.05 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.05 per unit of risk.

BCWORLD PHARM Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for BCWORLD PHARM's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BCWORLD PHARM Co, and traders can use it to determine the average amount a BCWORLD PHARM's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0545

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall Risk200780High RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.38
  actual daily
21
79% of assets are more volatile

Expected Return

 0.13
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
4
96% of assets perform better
Based on monthly moving average BCWORLD PHARM is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BCWORLD PHARM by adding it to a well-diversified portfolio.

BCWORLD PHARM Fundamentals Growth

BCWORLD Stock prices reflect investors' perceptions of the future prospects and financial health of BCWORLD PHARM, and BCWORLD PHARM fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BCWORLD Stock performance.

About BCWORLD PHARM Performance

By analyzing BCWORLD PHARM's fundamental ratios, stakeholders can gain valuable insights into BCWORLD PHARM's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BCWORLD PHARM has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BCWORLD PHARM has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about BCWORLD PHARM performance evaluation

Checking the ongoing alerts about BCWORLD PHARM for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BCWORLD PHARM help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BCWORLD PHARM Co has accumulated about 2.75 B in cash with (5.08 M) of positive cash flow from operations.
Roughly 39.0% of the company shares are owned by insiders or employees
Evaluating BCWORLD PHARM's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BCWORLD PHARM's stock performance include:
  • Analyzing BCWORLD PHARM's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BCWORLD PHARM's stock is overvalued or undervalued compared to its peers.
  • Examining BCWORLD PHARM's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BCWORLD PHARM's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BCWORLD PHARM's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of BCWORLD PHARM's stock. These opinions can provide insight into BCWORLD PHARM's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BCWORLD PHARM's stock performance is not an exact science, and many factors can impact BCWORLD PHARM's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for BCWORLD Stock analysis

When running BCWORLD PHARM's price analysis, check to measure BCWORLD PHARM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BCWORLD PHARM is operating at the current time. Most of BCWORLD PHARM's value examination focuses on studying past and present price action to predict the probability of BCWORLD PHARM's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BCWORLD PHARM's price. Additionally, you may evaluate how the addition of BCWORLD PHARM to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance